: iStockAnalyst.com Symbols Feed

Invest In HealthCare!

Tue, 01 Dec 2009 16:52:08 GMT

In 3 of the past 4 market rebounds since 1982, equity gains slowed to a single digit pace in the 2nd year, after the initial rally. Now dividend stocks have extra appeal because they offer a tempting alternative to CDs which pay virtually no interest at all, and long term bonds which pay a little bit more but leave you at the mercy of inflation. Established value companies in stable industries have usually proven a better long-term investment. Before S&P cut Pfizer (PFE) ratings to 'AA' from 'AAA' on Oct 16, 2009, there were 5 companies with AAA credit ratings: Automated Data Processing (ADP), Johnson & Johnson (JNJ), ExxonMobil (XOM) and Microsoft (MSFT). In other words, 2 out of 5 were healthcare companies.[More...]

7 Dividend Stocks To Take The Emotion Out Of Investing

Tue, 24 Nov 2009 13:48:11 GMT

Deep-down in my soul, I am a contrarian. The third quarter market run-up converted most of the great dividend stock buys into ‘ok' buys (at best). As September came to a close, I felt a sense of excitement entering October. This is the month that stocks have traditionally gone on sale. I was prepared to make a double allocation (or more) depending on the level of the markets decline. It didn't happen. Once again, investor emotions drove the market in an unpredictable direction.[More...]

Diabetes Care: Global Investing Opportunities

Mon, 23 Nov 2009 03:23:59 GMT

The American Diabetes Association estimates that there are currently 23.6 million diabetics in the U.S. (7.8% of the total population, including 17.9 million diagnosed cases, 5.7 million undiagnosed, and 57 million pre-diabetics. Diabetes results in an estimated $174 billion in costs from diagnosed cases of diabetes in the U.S. (2007).[More...]

A Winning Investment Strategy

Wed, 18 Nov 2009 15:39:58 GMT

We all want to succeed in everything that we do, including investing in the stock market. Though I have no analytical data to back it up, I am convinced that most people will lose money in the stock market over their lifetime. So why do so few people succeed at investing? Could it be that an individual's desire to succeed be a significant reason for their failure.[More...]

Most Active Stock Options November 9, 2009 & Trading Activity

Tue, 10 Nov 2009 03:12:59 GMT

As of today the top ten most active stock option contracts traded were: BP (BP) November 55 Call OptionsBP January 50 Call OptionsBP January 40 Call OptionsEli Lilly (LLY) January 30 Call OptionsS&P 500 SPDR (SPY) November 107 Put OptionsBP January 45 Call Options Bank of America (BAC) November 16 Call OptionsS&P 500 SPDR November 110[More...]

Big Pharma And Biotech - Industry Outlook

Mon, 09 Nov 2009 21:58:02 GMT

The pharmaceutical industry has witnessed major changes in 2009. Performance has been affected by factors like sluggish prescription trends, intensifying generic competition and limited phase III catalysts. The next five years are expected to reflect a significant imbalance between new product introductions and patent losses.[More...]

Wall Street Slumps On Wells Fargo Downgrade, JP Morgan (NYSE: JPM) Sinks

Wed, 21 Oct 2009 23:32:38 GMT

US stocks finished with losses after a bearish analyst note by Rochdale Securities' banking analyst Dick Bove rattled investors.[More...]

8 Dividend Stocks With The Right Stuff

Wed, 21 Oct 2009 16:56:18 GMT

What makes a good dividend stock? Every dividend growth investor is looking for a stock that will increase its dividend each and every year at a rate that makes the stock a better investment than fixed income alternatives. I have found that stocks that are able to do this share some common characteristics.[More...]

High-Yield Dividend Stocks: A Safer Approach

Tue, 13 Oct 2009 14:13:46 GMT

When people learn that I am an income investor, the reaction is often a desire to discuss high-yield investments. The uninitiated commonly confuse income investing with high-yield investing. The two are not the same.[More...]

20 High-Quality Stocks to Fall Back On

Mon, 28 Sep 2009 21:36:35 GMT

Given the uncertainty so characteristic of autumn, consider hunkering down with the stocks in our current Wide Moat Focus Index.[More...]

Indianapolis tennis event likely moving

Mon, 30 Nov 2009 15:36:00 GMT

Indianapolis tennis event likely moving[More...]

Being green isn't new marketing - it's good, established business

Sun, 15 Nov 2009 07:47:00 GMT

Corporate America is suddenly taking more credit for preserving the environment.
Because Americans have become so technology- oriented, we are increasingly creative, and we have found more novel ways to conserve resources in our businesses.
To reduce city water use, new tanks collect rain and faucets have been replaced.

: iStockAnalyst.com Symbols Feed

Invest In HealthCare!

7 Dividend Stocks To Take The Emotion Out Of Investing

Diabetes Care: Global Investing Opportunities

A Winning Investment Strategy

Most Active Stock Options November 9, 2009 & Trading Activity

Big Pharma And Biotech - Industry Outlook

Wall Street Slumps On Wells Fargo Downgrade, JP Morgan (NYSE: JPM) Sinks

8 Dividend Stocks With The Right Stuff

High-Yield Dividend Stocks: A Safer Approach

20 High-Quality Stocks to Fall Back On

Indianapolis tennis event likely moving

Being green isn't new marketing - it's good, established business

BioMS Medical Announces Third Quarter 2009 Results

Google, Yahoo call for expanded online drug ads

The Indianapolis Star Daniel Lee Column: Indiana Working to Create Its Own Identity With Investors

Eli Lilly to pay S. Carolina $45 million

Lilly Q3 Net Income Up

Eli Lilly CEO banking on new drug pipeline

Earnings Preview: Bristol-Myers 3Q earnings report

The Business Diary

China's Returnee Entrepreneurship: In the Right Place at the Right Time

Analyst Choice Initiates Market Analysis on Healthcare, Technology and Consumer Goods Sectors

ConocoPhillips up 21% Since Added to Galtstock Long-Term Portfolio

Phase Forward Reports Third Quarter 2009 Results

Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter

Licensing Executives Society Announces 2009 Deals of Distinction Awards

Best Practices to Speed-Up Pharmaceutical Analysis Processes From Johnson & Johnson, Pfizer, Genentech and Eli Lilly at Pharma IQ's Forum on Laboratory Informatics

PHT Corporation Promotes Dwight Cooper to Vice President of Client Services

Teva Provides Update on Generic Evista® Litigation

Deltagen Reports 2009 Second Quarter Financial Results

Form 4 LILLY ELI & CO For: Nov 30 Filed by: FELDSTEIN MARTIN S (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: SEIFERT KATHI P (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: PRENDERGAST FRANKLYN G (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: OBERHELMAN DOUGLAS R (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: MARRAM ELLEN R (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: HORN KAREN N (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: HOOVER R DAVID (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: Fyrwald J Erik (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: ESKEW MICHAEL L (10K)

Form 4 LILLY ELI & CO For: Nov 30 Filed by: BISCHOFF WINFRIED F W SIR (10K)